Prognostic value of the albumin–bilirubin grade in patients with hepatocellular carcinoma: Validation in a Chinese cohort
Hepatology Research2016Vol. 47(8), pp. 731–741
Citations Over TimeTop 10% of 2016 papers
Mu‐xing Li, Hong Zhao, Xinyu Bi, Zhi‐yu Li, Zhen Huang, Yue Han, Jianguo Zhou, Jianjun Zhao, Yefan Zhang, Jian‐qiang Cai
Abstract
The ALBI grade, which was featured by simplicity and objectivity, gained a superior prognostic value than that of C-P grade in patients with hepatocellular carcinoma who underwent liver resection. Future well-designed studies with larger sample sizes are warranted.
Related Papers
- → Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?(2018)22 cited
- Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.(2003)
- Spontaneous rupture of hepatocellular carcinoma.(2002)
- Pathology of hepatocellular carcinoma(2006)
- The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.(1997)